跳至主要内容
临床试验/DRKS00023260
DRKS00023260已完成不适用

ipidexchange capacity of low density lipoproteins depending on lipid-composition and Lp(a) - SAS092020

niversitätsklinikum Freiburg Institut für Klinische Chemie und Laboratoriumsmedizin0 个研究点目标入组 33 人开始时间: 2020年11月26日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
33

研究概览

简要总结

In this work, the S protein capacity to modulate HDL function was studied, by NR, ATR-FTIR and RCT experiments. The hypothesis was that the HDL capacity to remove and exchange lipids is impaired in presence of the S protein and this depends on the lipid saturation of the model membrane, cholesterol, and the lipid profile of the donor. Our research suggests that the S protein from the SARS-CoV-2 virus has a stronger ability to remove cholesterol and polyunsaturated lipids compared to saturated and monounsaturated ones. Coincubation of the S protein and HDL samples pooled from healthy adults with a fluid, saturated phospholipid model led to impaired HDL function, but the effect could be reverted when polyunsaturated lipids were used instead. This implies that the S protein preferentially removes polyunsaturated lipids from HDL, which leads to changes in its surface properties or remodelling.

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • written consent
  • healthy: triglycerides < 150 mg/dl and cholesterol < 200 mg/dl
  • Hypertriglyceridemia: triglycerides >150 mg/dl and cholesterol < 300 mg/dl
  • Hypercholesterolemia: triglyceride < 150 mg/dl and cholesterol >200 mg/dl

排除标准

  • severe Liver dysfunction
  • severe renal impairment
  • TSH not in reference range
  • Other serious internal diseases

研究者

发起方
niversitätsklinikum Freiburg Institut für Klinische Chemie und Laboratoriumsmedizin

相似试验